ABVC BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other
ABVC BioPharma, Inc. (ABVC) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other of $251.34 thousand as of 2019-02-08, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability › Business Combination, Recognized Liability Assumed, Liability, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther · last filed 2022-11-14
- 2019-02-08: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other $251.34K.
- 2018-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other $83.03K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other |
|---|---|
| 2019-02-08 | $251.34K 10-Q · filed 2022-11-14 |
| 2018-12-31 | $83.03K 10-K · filed 2019-04-15 |